Drug Compliance and Affecting Factors in Juvenile Idiopathic Arthritis
NCT06000566 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 174
Last updated 2024-05-03
Summary
The goal of this observational study is to learn about the drug compliance of patients with juvenile idiopathic arthritis and, to figure our factors that affect the compliance.
The main questions it aims to answer are:
* Medication use and compliance in children with chronic diseases is an important problem, but do patients with JIA really use their medications in harmony?
* Does the level of adherence to medications affect the quality of life of patients with JIA?
Participants will be asked to fill the demographic form which includes personal information and nutritional habbits, Morisky Drug Compliance Scale - 8 and the pediatric quality of life inventory forms, with attending researcher Yesfa Sebnem Ozbay, M.D.
This study is not an interventional study.
Conditions
- Arthritis, Juvenile Rheumatoid
- Medication Adherence
- Quality of Life
Sponsors & Collaborators
-
Yesfa Sebnem Ozbay
lead OTHER
Principal Investigators
-
Nuray Aktay Ayaz, M.D, M.Sci, Prof · IstabulU
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-01
- Primary Completion
- 2023-08-01
- Completion
- 2024-03-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism
NCT02926560 ·Status: COMPLETED
-
Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment
NCT02330250 ·Status: COMPLETED ·Phase: NA
-
Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
NCT07000916 ·Status: RECRUITING
-
Engagement in CHildhood-Onset Systemic Lupus
NCT05693571 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations
NCT02962960 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus
NCT02920424 ·Status: WITHDRAWN ·Phase: PHASE1
-
The Effect of Co-enzyme Q10 on the Clinical Outcome of Pediatric Patients With Systemic Lupus Erythematosus
NCT07096557 ·Status: COMPLETED ·Phase: PHASE2
-
Individual Patient Exposure and Response in Pediatric Lupus
NCT04358302 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects.
NCT06657703 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
NCT01436019 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus
NCT03161483 ·Status: COMPLETED ·Phase: PHASE2
-
Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
NCT01060410 ·Status: COMPLETED
-
Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy
NCT01856569 ·Status: COMPLETED
-
Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus
NCT00004665 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CSL730 in Healthy Adult Subjects
NCT04446000 ·Status: TERMINATED ·Phase: PHASE1
-
Headache in Juvenile Onset Systemic Lupus Erythematosus
NCT06658457 ·Status: COMPLETED
-
Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupus
NCT02558517 ·Status: UNKNOWN ·Phase: PHASE3
-
Pilot Feasibility Study of a Sjögren's Syndrome Self-management App
NCT04653935 ·Status: UNKNOWN ·Phase: NA
-
Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE
NCT05230316 ·Status: UNKNOWN
-
JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
NCT06675422 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Five-Year Actively Controlled Clinical Trial in New Onset Juvenile Systemic Lupus Erythematosus Nephritis
NCT00336414 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE
NCT07306585 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study of CM355 in Patients With Systemic Lupus Erythematosus
NCT07104344 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis
NCT04737343 ·Status: UNKNOWN ·Phase: NA
-
A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus
NCT05465707 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2